TABLE 6.
Action potential (AP), Ca2+ transients (CaT), and active tension (AT) calculated biomarkers in spontaneous condition and their comparison with Paci2020 and hiPSC-CM-CE model (i.e. no metabolite-sensitive CE) and the experimental values (Paci et al., 2018; Paci et al., 2020). APA: AP amplitude, MDP: maximum diastolic potential, CL: cycle length, dV/dt max: maximum upstroke velocity, APD10 and APD30 and APD90: AP duration at 10, 30, 90% of repolarization, respectively, AP Tri: AP triangulation index. The simulated biomarkers of CaT are DURATION: duration of the transient, tRise10, peak: time to peak, tRise10, 50 and tRise10, 90: rise time from 10 to 50% and 90% of maximum threshold, respectively, and tDecay90,10: decay time from 90 to 10%. AT: Active tension, RT50: time from peak contraction to 50% of relaxation, %FS: percent of fractional shortening. The experimental ranges for contraction biomarkers are from (Forouzandehmehr et al., 2021). The third column is taken directly from the original Paci2020 publication (Paci et al., 2020).
No. | Biomarker | Paci2020 | hiPSC-CM-CE | hiMCE | Exp. Value (Mean ± SD) |
---|---|---|---|---|---|
1 | APA (mV) | 102 | 103 | 103 | 104 ± 6 |
2 | MDP (mV) | -74.9 | -75.0 | -75.0 | -75.6 ± 6.6 |
3 | AP CL (ms) | 1712 | 1644 | 1644 | 1700 ± 548 |
4 | dV/dt max (V/s) | 20.5 | 23.9 | 24.0 | 27.8 ± 26.3 |
5 | APD10 (ms) | 87.0 | 95.0 | 95.1 | 74.1 ± 26.3 |
6 | APD30 (ms) | 224 | 238 | 238 | 180 ± 59 |
7 | APD90 (ms) | 390 | 403 | 403 | 415 ± 119 |
8 | AP Tri | 2.8 | 2.9 | 3 | 2.5 ± 1.1 |
9 | CaT DURATION (ms) | 691 | 693 | 693 | 805 ± 188 |
10 | CaT tRise10, peak (ms) | 184 | 163 | 163 | 270 ± 108 |
11 | CaT tRise10,50 (ms) | 54.9 | 46.2 | 45.9 | 82.9 ± 50.5 |
12 | CaT tRise10,90 (ms) | 118 | 102 | 102 | 167 ± 70 |
13 | CaT tDecay90,10 (ms) | 341 | 343 | 343 | 410 ± 100 |
14 | AT magnitude (kPa) | - | 0.055 | 0.055 | 0.055 ± 0.009 |
15 | RT50 (ms) | - | 161 | 158 | 158 ± 12.1 |
16 | %FS | - | 3.45 | 3.23 | 3.27 ± 0.37 |